Status:

COMPLETED

The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy

Lead Sponsor:

Third Military Medical University

Conditions:

Microcirculation Detection in Diabetic Patients

Eligibility:

All Genders

18-70 years

Brief Summary

Diabetic microangiopathy refers to the pathological changes of arterioles, capillaries and venules in diabetic patients. Due to the impacts including glycol-metabolism disorder, disturbance of lipid m...

Eligibility Criteria

Inclusion

  • age ranges from 18 to 70 years old
  • signed informed consent

Exclusion

  • Younger than 18 years old or older than 70 years old
  • Shock patients who have low blood pressure under 90/60mmHg
  • Patients with mental abnormality who are uncooperative with this study
  • Having difficulty in mouth opening
  • Patients with Ketoacidosis
  • Oral mucosal inflammation or injury, which could locally influence the sublingual microvasculature
  • Pregnant or lactating women
  • Refuse to sign informed consent

Key Trial Info

Start Date :

June 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2021

Estimated Enrollment :

143 Patients enrolled

Trial Details

Trial ID

NCT04403945

Start Date

June 1 2019

End Date

March 1 2021

Last Update

July 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The third hospital affiliated to the Third Military Medical University

Chongqing, Chongqing Municipality, China, 400042